Clinical Trial Update: Memantine and Validation of a New Alzheimer's Disease Scale [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of memantine has completed and includes validation of a new Alzheimer's disease assessment scale. The sponsor is Merz Pharmaceuticals Gmb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED